Purpose To evaluate how the monitoring and treatment for diabetic macular edema (DME)
has changed in a national sample. Design Retrospective cohort study. Methods Setting …

Objectives To characterize diabetic macular edema (DME) treatment patterns in Taiwan and
examine their impact on health care resource utilization and visual and anatomic outcomes …

Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults. DR
often leads to diabetic macular edema (DME), which often goes unnoticed until a patient …

Purpose To provide evidence-based recommendations for diabetic macular edema (DME)
management based on updated information from publications on DME treatment modalities …

Purpose To determine monitoring and treatment patterns and vision outcomes in real-world
patients initiating anti–vascular endothelial growth factor (anti-VEGF) therapy for diabetic …

BACKGROUND AND OBJECTIVE: To characterize vascular endothelial growth factor
(VEGF) inhibitor treatment patterns in patients with diabetic macular edema (DME) using a …

Diabetic macular edema (DME) is the most common cause of visual impairment in patients
with diabetes mellitus and affects B6. 8% of the diabetic population. 1 The Diabetes Control …

Purpose To describe the treatment patterns and the predictors of different treatment
standards in recently diagnosed diabetic macular edema (DME) patients in a nationally …

Purpose To report the long-term outcomes of intravitreal anti–vascular endothelial growth
factor (VEGF) treatment for diabetic macular edema (DME) in a real-world clinical setting …

Background The treatment for diabetic macular edema (DME) has revolutionized during the
last 15 years after the introduction of intravitreal anti-VEGF agents. The aim of the current …